Tuesday, November 15, 2016
- 9:00AM-11:00AM
-
Abstract Number: 2640
Can GP88 (Progranulin) be Used to Predict the Efficacy of Infliximab?
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2381
Canakinumab Monotherapy for the Treatment of Majeed Syndrome. Five-Year Experience
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster III: Systemic JIA, Autoinflammatory Syndromes, Scleroderma, Vasculitis, Miscellaneous- 9:00AM-11:00AM
-
Abstract Number: 2327
Cardiac Involvement in Inflammatory Myopathies: A Report from the Remicam Registry
Muscle Biology, Myositis and Myopathies - Poster II: Clinical- 9:00AM-11:00AM
-
Abstract Number: 2097
Cardiolipin-Producing Candidate Commensals in the Gut Microbiome of Antiphospholipid Syndrome Patients
Antiphospholipid Syndrome - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2293
Cardiometabolic Risk and Subclinical Urate Deposits in Patients with Symptomatic Hyperuricemia and Metabolic Syndrome
Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease- 9:00AM-11:00AM
-
Abstract Number: 2170
Cardiovascular Risk in Patients with Psoriasis, Psoriatic and Rheumatoid Arthritis: A Prospective Study Using Secured Anonymised Information Technology Databank in Wales, United Kingdom
Epidemiology and Public Health - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2611
Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2437
Causes of Cesarean Section and Labor Induction in Systemic Lupus Erythematosus and Rheumatoid Arthritis Pregnancies
Reproductive Issues in Rheumatic Disorders - Poster- 9:00AM-11:00AM
-
Abstract Number: 2136
CD14 Deficiency Delays Progression of Cartilage Degeneration and Protects Against Early Deficits in Functional Outcomes in a Murine Osteoarthritis Model
Biology and Pathology of Bone and Joint - Poster I- 9:00AM-11:00AM
-
Abstract Number: 2874
CD16+monocytes Are Enriched and Functionally Exacerbated in Driving B Cell Activation Under Systemic Lupus Erythematosus Condition
Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2882
CD4+ T Helper Cells and Regulatory T Cells in Active Lupus Nephritis – an Imbalance Towards a Predominant Th1 Response?
Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2421
Cell-Bound Complement Activation Products Correlate with Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
Pediatric Rheumatology – Pathogenesis and Genetics - Poster- 9:00AM-11:00AM
-
Abstract Number: 2800
Cell-Bound Complement Activation Products in Multi-Analyte Assay with Algorithm Aid the Diagnosis of Systemic Lupus Erythematosus